Pharmacogenomic Testing and Depressive Symptom Remission: A Systematic Review and Meta‐Analysis of Prospective, Controlled Clinical Trials

Pharmacogenomic (PGx) testing has emerged as a compelling strategy that clinicians can use to inform antidepressant medication selection and dosing, but the clinical efficacy of this strategy has been questioned. We systematically reviewed and meta‐analyzed clinical trials for an association between...

Descripción completa

Detalles Bibliográficos
Autores principales: Brown, Lisa C., Stanton, Joseph D., Bharthi, Kanika, Maruf, Abdullah Al, Müller, Daniel J., Bousman, Chad A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9827897/
https://www.ncbi.nlm.nih.gov/pubmed/36111494
http://dx.doi.org/10.1002/cpt.2748

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9827897/
https://www.ncbi.nlm.nih.gov/pubmed/36111494
http://dx.doi.org/10.1002/cpt.2748

Ejemplares similares